Logo

ASTM F1027-86(2002)

Historical Reaffirmation

Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices (Withdrawn 2023)

$91.00

$91.00

$163.80


Sub Total (1 Item(s))

$ 0.00

Estimated Shipping

$ 0.00

Total (Pre-Tax)

$ 0.00


...

1.1 This practice describes a procedure to assess the cytotoxic potential of materials for use in the construction of medical materials and devices using human excised donor (HED) tissues and their derived primary cells taken from the orofacial region.

1.2 This practice may be used either directly to evaluate materials or as a reference against which other cytotoxicity methods may be compared.

1.3 This practice is one of a series of reference methods for assessment of cytotoxic potential, employing different techniques.

1.4 Assessment of cytotoxicity is one of several procedures employed in determining the biological response to a material, as recommended in Practice F748.

1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.


SDO ASTM: ASTM International
Document Number F1027
Publication Date Jan. 1, 2002
Language en - English
Page Count 11
Revision Level 86(2002)
Supercedes
Committee F04.16
Publish Date Document Id Type View
Nov. 1, 2017 F1027-86R17 Revision
Oct. 1, 2012 F1027-86R12 Reaffirmation
Feb. 1, 2007 F1027-86R07 Reaffirmation
Jan. 1, 2002 F1027-86R02 Reaffirmation
Jan. 1, 1995 F1027-86R95E01 Reaffirmation